GSK-3β suppresses HCC cell dissociation in vitro by upregulating epithelial junction proteins and inhibiting Wnt/β-catenin signaling pathway.
about
ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway.miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma
P2860
GSK-3β suppresses HCC cell dissociation in vitro by upregulating epithelial junction proteins and inhibiting Wnt/β-catenin signaling pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
GSK-3β suppresses HCC cell dis ...... t/β-catenin signaling pathway.
@en
type
label
GSK-3β suppresses HCC cell dis ...... t/β-catenin signaling pathway.
@en
prefLabel
GSK-3β suppresses HCC cell dis ...... t/β-catenin signaling pathway.
@en
P2093
P2860
P356
P1433
P1476
GSK-3β suppresses HCC cell dis ...... t/β-catenin signaling pathway.
@en
P2093
Jian-Wei Zhou
Jing-Hua Zhang
Li-Yan Jiao
Tie-Jun Li
York Yuanyuan Zhu
P2860
P304
P356
10.7150/JCA.18744
P577
2017-06-03T00:00:00Z